LPCN
LPCN
NASDAQ · Pharmaceuticals

Lipocine Inc

$2.43
+0.10 (+4.29%)
As of May 9, 2:13 AM ET ·
Financial Highlights (FY 2026)
Revenue
2.96M
Net Income
-14,412,985
Gross Margin
Profit Margin
-487.1%
Rev Growth
+58.1%
D/E Ratio
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 28.1% 28.1%
Operating Margin -524.7% -472.2% 13.6% 14.9%
Profit Margin -487.1% -462.7% 16.1% 15.9%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 2.96M 1.87M 22.16M 17.20M
Gross Profit 6.23M 4.83M
Operating Income -15,527,869 -8,838,276 3.02M 2.56M
Net Income -14,412,985 -8,203,697 3.56M 2.74M
Gross Margin 28.1% 28.1%
Operating Margin -524.7% -472.2% 13.6% 14.9%
Profit Margin -487.1% -462.7% 16.1% 15.9%
Rev Growth +58.1% +58.1% +9.7% +22.0%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 0 0 4.92M 5.58M
Total Equity 36.70M 40.60M
D/E Ratio 0.13 0.14
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -15,435,084 -9,273,545 4.85M 3.77M
Free Cash Flow 3.49M 2.02M